A synthetic molecule targeting STAT3 against human oral squamous cell carcinoma cells

被引：0
|
作者：
Bai, Li-Yuan [1 ,2 ]
Dokla, Eman M. E. [3 ]
Chu, Po-Chen [4 ,5 ]
Feng, Chia-Hsien [6 ]
Hu, Jing-Lan [1 ]
Wang, Liang-Jun [7 ]
Weng, Jing-Ru [7 ,8 ,9 ]
机构：
[1] China Med Univ Hosp, Dept Internal Med, Div Hematol & Oncol, Taichung 404, Taiwan
[2] China Med Univ, Coll Med, Taichung 404, Taiwan
[3] Ain Shams Univ, Fac Pharm, Pharmaceut Chem Dept, Cairo 11566, Egypt
[4] China Med Univ, Dept Cosmeceut, Taichung 404, Taiwan
[5] China Med Univ, Grad Inst Cosmeceut, Taichung 404, Taiwan
[6] Kaohsiung Med Univ, Coll Pharm, Dept Fragrance & Cosmet Sci, Kaohsiung 807, Taiwan
[7] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 804, Taiwan
[8] Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung 807, Taiwan
[9] Taipei Med Univ, Grad Inst Pharmacognosy, Coll Pharm, Taipei 110, Taiwan
来源：
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES | 2025年 / 22卷 / 05期
关键词：
Oral squamous cell carcinoma; apoptosis; migration; MAPK; STAT3; TYROSINE KINASE INHIBITOR; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER CELLS; KAPPA-B; GROWTH; RECEPTOR; EXPRESSION; ACTIVATION; PATHWAY; HEAD;
D O I：
10.7150/ijms.105200
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Oral squamous cell carcinoma (OSCC), one of the most common cancers in Taiwan, needs new therapeutic agents and treatments. The aim of this study was to investigate the anti-proliferative activity of nyl]-1,2,4-oxadiazol-3-yl]phenyl]-3-pyridine-carboxamide} (COC), a synthetic molecule, in OSCC cells. COC exhibits potent tumor-suppressive efficacy with IC50 values of 195 nM and 204 nM toward SCC2095 and SCC4 OSCC cells, respectively. Our data revealed that COC caused caspase-dependent apoptosis and downregulated the MAPK signaling pathway. In addition, COC modulated the levels of E-cadherin and beta-catenin and inhibited migration. COC also decreased p-STAT3 levels, and the overexpression of STAT3 partially attenuated COC-induced cytotoxicity. Therefore, our findings suggest the use of COC as a new approach to oral cancer treatment.
引用
收藏
页码：1081 / 1091
页数：11
相关论文
共 50 条
  • [21] Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin
    Liu, Tingyan
    Peng, Huaguang
    Zhang, Meixia
    Deng, Yihui
    Wu, Zhenghu
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 641 (01) : 15 - 22
  • [22] MicroRNA-29a functions as a tumor suppressor through targeting STAT3 in laryngeal squamous cell carcinoma
    Liu, Yi-Bin
    Wang, Ying
    Zhang, Ming-De
    Yue, Wei
    Sun, Chi-Nan
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2020, 116
  • [23] Silencing STAT3 with short hairpin RNA enhances radiosensitivity of human laryngeal squamous cell carcinoma xenografts in vivo
    Li, Xiaoming
    Wang, Hairu
    Lu, Xiuying
    Di, Bin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2010, 1 (06) : 947 - 953
  • [24] Astaxanthin inhibits hallmarks of cancer by targeting the PI3K/NF-κΒ/STAT3 signalling axis in oral squamous cell carcinoma models
    Kowshik, Jaganathan
    Nivetha, Ramesh
    Ranjani, Singaraj
    Venkatesan, Palanivel
    Selvamuthukumar, Subramanian
    Veeravarmal, Veeran
    Nagini, Siddavaram
    IUBMB LIFE, 2019, 71 (10) : 1595 - 1610
  • [25] Knockdown of MSI1 inhibits the proliferation of human oral squamous cell carcinoma by inactivating STAT3 signaling
    Wang, Chen-Fei
    Zhang, Hong-Chuang
    Feng, Xin-Mei
    Song, Xiao-Meng
    Wu, Yu-Nong
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 44 (01) : 115 - 124
  • [26] STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells
    Zhang, Chuanhai
    Guo, Fenglin
    Xu, Geliang
    Ma, Jie
    Shao, Feng
    ONCOLOGY REPORTS, 2015, 33 (04) : 1872 - 1882
  • [27] Licochalcone C induced apoptosis in human oral squamous cell carcinoma cells by regulation of the JAK2/STAT3 signaling pathway
    Oh, Ha-Na
    Seo, Ji-Hye
    Lee, Mee-Hyun
    Kim, Cheolhee
    Kim, Eunae
    Yoon, Goo
    Cho, Seung-Sik
    Cho, Young Sik
    Choi, Hyun Woo
    Shim, Jung-Hyun
    Chae, Jung-Il
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (12) : 10118 - 10130
  • [28] Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines
    Couto, Jason I.
    Bear, Misty D.
    Lin, Jiayuh
    Pennel, Michael
    Kulp, Samuel K.
    Kisseberth, William C.
    London, Cheryl A.
    BMC VETERINARY RESEARCH, 2012, 8
  • [29] Vitexin abrogates invasion and survival of hepatocellular carcinoma cells through targeting STAT3 signaling pathway
    Lee, Jong Hyun
    Mohan, Chakrabhavi Dhananjaya
    Shanmugam, Muthu K.
    Rangappa, Shobith
    Sethi, Gautam
    Siveen, Kodappully Sivaraman
    Chinnathambi, Arunachalam
    Alahmadi, Tahani Awad
    Alharbi, Sulaiman Ali
    Basappa, Salundi
    Rangappa, Kanchugarakoppal S.
    Ahn, Kwang Seok
    BIOCHIMIE, 2020, 175 : 58 - 68
  • [30] Stat3 expression in oral squamous cell carcinoma: association with clinicopathological parameters and survival
    Shah, N. G.
    Trivedi, T. I.
    Tankshali, R. A.
    Goswami, J. A.
    Jetly, D. H.
    Kobawala, T. P.
    Shukla, S. N.
    Shah, P. M.
    Verma, R. J.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2006, 21 (03) : 175 - 183
12345